The Analysis of B-Cell Epitopes of Influenza Virus Hemagglutinin.
Ontology highlight
ABSTRACT: Vaccination has been successfully used to prevent influenza for a long time. Influenza virus hemagglutinin (HA), which induces a humoral immune response in humans and protection against the flu, is the main antigenic component of modern influenza vaccines. However, new seasonal and pandemic influenza virus variants with altered structures of HA occasionally occur. This allows the pathogen to avoid neutralization with antibodies produced in response to previous vaccination. Development of a vaccine with the new variants of HA acting as antigens takes a long time. Therefore, during an epidemic, it is important to have passive immunization agents to prevent and treat influenza, which can be monoclonal or single-domain antibodies with universal specificity (broad-spectrum agents). We considere
SUBMITTER: Shcherbinin DN
PROVIDER: S-EPMC4837568 | biostudies-literature | 2016 Jan-Mar
REPOSITORIES: biostudies-literature
ACCESS DATA